Condition:
Cognitive-behavioral coping skills therapy (CBT) is a widely used and recognized treatment that has been empirically validated for a range of substance use disorders, often with emergent effects and continuing improvement even after treatment ends. Treatment retention and compliance are associated with enhanced treatment outcomes in CBT. Contingency management (CM) also has very strong support and is associated with rapid, robust effects on targeted outcomes. Despite their many strengths, neither CBT nor CM is universally effective. It is now essential to seek strategies to maximize and extend the effectiveness of these two approaches and to better understand how these treatments exert their effects.
Dates: December 2004 -
Study Status: Recruiting
Ages Eligible: 18 Years - 65 Years
Gender Eligible: Both
Inclusion Criteria:
Exclusion Criteria:
Sponsor:
Phase: Phase 2
First Received: July 7, 2006
Last Updated: Sep 14, 2009
Clinicaltrials.gov ID:
NCT00350649
Study HIC # 0407026913
Condition:
Interventions: Behavioral: Standard CBT;
Behavioral: CBT+CM/adherence;
Behavioral: CM/abstinence;
Behavioral: CM/abstinence+CBT
Cognitive-behavioral coping skills therapy (CBT) is a widely used and recognized treatment that has been empirically validated for a range of substance use disorders, often with emergent effects and continuing improvement even after treatment ends. Treatment retention and compliance are associated with enhanced treatment outcomes in CBT. Contingency management (CM) also has very strong support and is associated with rapid, robust effects on targeted outcomes. Despite their many strengths, neither CBT nor CM is universally effective. It is now essential to seek strategies to maximize and extend the effectiveness of these two approaches and to better understand how these treatments exert their effects.
Dates: December 2004 -
Study Status: Recruiting
Ages Eligible: 18 Years - 65 Years
Gender Eligible: Both
Inclusion Criteria:
- 18-65 year old marijuana dependent
- willing to sign consent
- no use of prescribed psychotropic drugs
- willing to give three individuals as contacts
- willing to accept randomization
- read and write English (third grade level)
Exclusion Criteria:
- unable to commit to 1 year follow up
Sponsor:
Phase: Phase 2
First Received: July 7, 2006
Last Updated: Sep 14, 2009
Clinicaltrials.gov ID:
NCT00350649
Study HIC # 0407026913
JoAnna DePiono, BA
203-974-5731
joanna.depino@yale.edu
Rhonda Pruzinski, BA
203-974-5740
rhonda.pruzinski@yale.edu
Carroll, Kathleen M.
Principal Investigator
HIC # 0805003779